A2AR is closely related with neurodegeneration [77] and demonstrated a positive effect after blockage of A2AR in neurodegenerative models, such as Parkinson disease (PD) [78,79], Alzheimer disease (AD) [80] and ischemia [81]. Here, ADORA2A is linked to early-onset autosomal dominant Alzheimer disease.